The levels of m6A methylation regulators were related to the overall survival and immunity in HCC, and METTL3, METTL13, YTHDF1, and YTHDF2 might be potential prognosis predictors and therapeutic targets in HCC (104, 105). The gene discussed is YTHDF2; the disease is hepatocellular carcinoma.